|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 413/12 | |
| A61K 31/505 | |||
| A61P 31/18 |
| (11) | Number of the document | 2796458 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14176804.4 |
| Date of filing the European patent application | 2011-04-01 | |
| (97) | Date of publication of the European application | 2014-10-29 |
| (45) | Date of publication and mention of the grant of the patent | 2018-01-10 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 320062 P | 2010-04-01 | US | |
| 326922 P | 2010-04-22 | US | |
| 329284 P | 2010-04-29 | US | |
| 353398 P | 2010-06-10 | US | |
| 392770 P | 2010-10-13 | US | |
| 392759 P | 2010-10-13 | US | |
| 417632 P | 2010-11-29 | US |
| (72) |
Kwokal, Ana, HR
Hedvati, Lilach, IL
Burstein, Revital, IL
Yeori, Adi, IL
Moshkovits-Kaptsan, Rinat, IL
|
| (73) |
Teva Pharmaceutical Industries Ltd.,
5 Basel Street P.O. Box 3190, 49131 Petah Tiqva,
IL
|
| (54) | Crystalline raltegravir sodium salts |
| Crystalline raltegravir sodium salts |